H. Johnson

Adverse Drug Reactions: Type A (Intrinsic) or Type B (Idiosyncratic).

C. Iasella, H. Johnson, M. Dunn, 2017, Clinics in liver disease.

The pharmacokinetics of a single oral dose of mycophenolate mofetil in patients with varying degrees of renal function

S. Swan, A. Nicholls, H. Johnson, 1998, Clinical pharmacology and therapeutics.

A randomized trial comparing cyclosporine induction with sequential therapy in renal transplant recipients

B. Kasiske, A. Ney, H. Johnson, 1997 .

Incidence and Management of Rash in Telaprevir-Treated Patients

Michael A. Smith, H. Johnson, M. Dunn, 2014, The Annals of pharmacotherapy.

An evaluation of the safety and preliminary efficacy of peri‐ and post‐operative treprostinil in preventing ischemia and reperfusion injury in adult orthotopic liver transplant recipients

A. Demetris, M. Molinari, A. Humar, 2021, Clinical transplantation.

Low vitamin D exposure is associated with higher risk of infection in renal transplant recipients

A. Humar, R. Venkataramanan, H. Kalluri, 2017, Clinical Transplantation.

Population Pharmacokinetic Evaluation with External Validation and Bayesian Estimator of Voriconazole in Liver Transplant Recipients

R. Bies, R. Venkataramanan, H. Johnson, 2011, Clinical pharmacokinetics.

Voriconazole Pharmacokinetics in Liver Transplant Recipients

M. Romkes, D. Paterson, R. Venkataramanan, 2009, Antimicrobial Agents and Chemotherapy.

Variable exposure to fixed-dose voriconazole in liver transplant recipients

D. Paterson, R. Venkataramanan, P. Linden, 2008 .

Drug Class Combination–Associated Acute Kidney Injury

John A Kellum, Joseph F Dasta, Pamela L Smithburger, 2016, The Annals of pharmacotherapy.

A randomized trial comparing cyclosporine induction with sequential therapy in renal transplant recipients.

B. Kasiske, A. Ney, H. Johnson, 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.